GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synergy Pharmaceuticals Inc (FRA:S90) » Definitions » Inventory Turnover

Synergy Pharmaceuticals (FRA:S90) Inventory Turnover : 0.20 (As of Sep. 2018)


View and export this data going back to 2012. Start your Free Trial

What is Synergy Pharmaceuticals Inventory Turnover?

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Synergy Pharmaceuticals's Cost of Goods Sold for the three months ended in Sep. 2018 was €3.36 Mil. Synergy Pharmaceuticals's Average Total Inventories for the quarter that ended in Sep. 2018 was €16.76 Mil. Synergy Pharmaceuticals's Inventory Turnover for the quarter that ended in Sep. 2018 was 0.20.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Synergy Pharmaceuticals's Days Inventory for the three months ended in Sep. 2018 was 455.08.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Synergy Pharmaceuticals's Inventory-to-Revenue for the quarter that ended in Sep. 2018 was 1.76.


Synergy Pharmaceuticals Inventory Turnover Historical Data

The historical data trend for Synergy Pharmaceuticals's Inventory Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synergy Pharmaceuticals Inventory Turnover Chart

Synergy Pharmaceuticals Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Inventory Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.75

Synergy Pharmaceuticals Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Inventory Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.25 0.22 0.24 0.20

Synergy Pharmaceuticals Inventory Turnover Calculation

Synergy Pharmaceuticals's Inventory Turnover for the fiscal year that ended in Dec. 2017 is calculated as

Inventory Turnover (A: Dec. 2017 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (A: Dec. 2017 ) / ((Total Inventories (A: Dec. 2016 ) + Total Inventories (A: Dec. 2017 )) / count )
=7.445 / ((5.347 + 14.546) / 2 )
=7.445 / 9.9465
=0.75

Synergy Pharmaceuticals's Inventory Turnover for the quarter that ended in Sep. 2018 is calculated as

Inventory Turnover (Q: Sep. 2018 )
=Cost of Goods Sold / Average Total Inventories
=Cost of Goods Sold (Q: Sep. 2018 ) / ((Total Inventories (Q: Jun. 2018 ) + Total Inventories (Q: Sep. 2018 )) / count )
=3.361 / ((15.073 + 18.451) / 2 )
=3.361 / 16.762
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synergy Pharmaceuticals  (FRA:S90) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Synergy Pharmaceuticals's Days Inventory for the three months ended in Sep. 2018 is calculated as:

Days Inventory =Average Total Inventories (Q: Sep. 2018 )/Cost of Goods Sold (Q: Sep. 2018 )*Days in Period
=16.762/3.361*365 / 4
=455.08

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Synergy Pharmaceuticals's Inventory to Revenue for the quarter that ended in Sep. 2018 is calculated as

Inventory-to-Revenue=Average Total Inventories (Q: Sep. 2018 ) / Revenue (Q: Sep. 2018 )
=16.762 / 9.517
=1.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.


Synergy Pharmaceuticals Inventory Turnover Related Terms

Thank you for viewing the detailed overview of Synergy Pharmaceuticals's Inventory Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Synergy Pharmaceuticals (FRA:S90) Business Description

Traded in Other Exchanges
N/A
Address
420 Lexington Avenue, Suite 2012, New York, NY, USA, 10170
Synergy Pharmaceuticals Inc functions in the healthcare sector based in the United States. It focusses on developing therapies to combat gastrointestinal diseases. The company's basic ingredient is the uroguanylin analog, which it employs in its products candidates such as plecanatide and dolcanatide. Plecanatide is a once-daily tablet, which addresses chronic idiopathic constipation and the irritable bowel syndrome. Dolcanatide is meant to cure inflammatory bowel disease by aiding the process of digestive breakdown.

Synergy Pharmaceuticals (FRA:S90) Headlines

No Headlines